The change over recent decades in perceptions of the role of viruses in hum
an cancer-causation is illustrated by the reception given to the discovery
of Epstein-Barr virus (EBV) in 1964 compared to that of Kaposi's sarcoma he
rpesvirus (KSHV or HHV-8) in 1994.
Very new data on EBV-like agents in New World monkeys is considered in rela
tion to the antiquity of the association of proto-EBV with early anthropoid
s.
Although the finding that individuals without B lymphocytes do not seem to
be infected with EBV appears to have resolved the controversy regarding the
permissive cell type producing infectious virus in the oropharynx, the pre
sence of EBV in certain squamous and other epithelial cells raises continui
ng problems which are discussed.
Among many recent successes of molecular biology applied to EBV, new inform
ation from such investigations on the genetic defect in X-linked lymphoprol
iferative syndrome now explains the cause of the disastrous pathological ch
anges underlying the disease.
Finally, current progress with vaccines against EBV is reviewed. (C) 2001 T
he British Infection Society.